Literature DB >> 22391593

Re: In response to "Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma".

Dildar Bahar Genc, Cengiz Canpolat, Su Gulsun Berrak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22391593     DOI： 10.1007/s00520-012-1421-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  3 in total

1.  In response to "Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma".

Authors:  Lucie Lafay-Cousin; Eric Bouffet
Journal:  Support Care Cancer       Date:  2011-11-11       Impact factor: 3.603

2.  Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma.

Authors:  Dildar Bahar Genc; Cengiz Canpolat; Su Gulsun Berrak
Journal:  Support Care Cancer       Date:  2011-03-17       Impact factor: 3.603

3.  Temozolomide in pediatric low-grade glioma.

Authors:  Seong L Khaw; Lee T Coleman; Peter A Downie; John A Heath; David M Ashley
Journal:  Pediatr Blood Cancer       Date:  2007-11       Impact factor: 3.167
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.